ATE120955T1 - Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen. - Google Patents

Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen.

Info

Publication number
ATE120955T1
ATE120955T1 AT88121405T AT88121405T ATE120955T1 AT E120955 T1 ATE120955 T1 AT E120955T1 AT 88121405 T AT88121405 T AT 88121405T AT 88121405 T AT88121405 T AT 88121405T AT E120955 T1 ATE120955 T1 AT E120955T1
Authority
AT
Austria
Prior art keywords
benzylidene
proliferative processes
chem
group
mammal cells
Prior art date
Application number
AT88121405T
Other languages
English (en)
Inventor
Alexander Levitzki
Chaim Gilon
Michael Chorev
Aviv Gazit
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL84937A external-priority patent/IL84937A/xx
Priority claimed from IL88354A external-priority patent/IL88354A0/xx
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE120955T1 publication Critical patent/ATE120955T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Steroid Compounds (AREA)
AT88121405T 1987-12-24 1988-12-21 Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen. ATE120955T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL84937A IL84937A (en) 1987-12-24 1987-12-24 Pharmaceutical compositions comprising benzylidene- malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
IL88354A IL88354A0 (en) 1988-11-10 1988-11-10 Pharmaceutical compositions comprising benzylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells,certain such novel compounds and their preparation

Publications (1)

Publication Number Publication Date
ATE120955T1 true ATE120955T1 (de) 1995-04-15

Family

ID=26321754

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88121405T ATE120955T1 (de) 1987-12-24 1988-12-21 Benzyliden-malononitril-derivate zur hemmung von proliferativen prozessen in säugetierzellen.

Country Status (8)

Country Link
EP (2) EP0614661A3 (de)
JP (2) JP2806954B2 (de)
AT (1) ATE120955T1 (de)
AU (1) AU632992B2 (de)
CA (1) CA1334826C (de)
DE (1) DE3853577T2 (de)
ES (1) ES2073398T3 (de)
NZ (1) NZ227436A (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68917357T2 (de) * 1988-04-28 1995-01-26 Suntory Ltd Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
CA2080582A1 (en) * 1990-04-16 1991-10-17 Alfred P. Spada Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
CA2080554A1 (en) * 1991-10-15 1993-04-16 Mitsubishi Chemical Corporation Styrene derivatives
JPH05301838A (ja) * 1991-10-15 1993-11-16 Mitsubishi Kasei Corp スチレン誘導体
DE4230262A1 (de) * 1992-09-10 1994-03-17 Behringwerke Ag Substituierte Phenole, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von zellproliferationsbedingten Erkrankungen
US5763441A (en) * 1992-11-13 1998-06-09 Sugen, Inc. Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
US5981569A (en) * 1992-11-13 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Substituted phenylacrylonitrile compounds and compositions thereof for the treatment of disease
GB9323290D0 (en) 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
IL107736A (en) * 1993-11-24 2001-01-11 Yissum Res Dev Co Pharmaceutical composition for the prevention of septic shock and for the treatment of chronic inflammatory diseases
IL119069A0 (en) * 1996-08-14 1996-11-14 Mor Research Applic Ltd Pharmaceutical composition comprising tyrphostins
DE69918950T2 (de) * 1998-02-06 2005-07-28 De Montfort University Durch hydroxylierung aktivierte medikamentvorstufen
GB9802522D0 (en) 1998-02-06 1998-04-01 Montford University De Hydroxylation activated prodrugs
GB2334256A (en) 1998-02-12 1999-08-18 Univ Montfort Hydroxylation activated prodrugs
US6432979B1 (en) 1999-08-12 2002-08-13 American Cyanamid Company Method of treating or inhibiting colonic polyps and colorectal cancer
AU2001248201B2 (en) 2000-04-13 2006-12-14 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
US6582919B2 (en) 2001-06-11 2003-06-24 Response Genetics, Inc. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
WO2003009807A2 (en) 2001-07-23 2003-02-06 Galileo Laboratories, Inc. Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
US20050014690A1 (en) * 2001-10-11 2005-01-20 Chaim Roifman Styryl acrylonitrile compounds and their use to promote myelopoiesis
WO2005092904A1 (en) 2004-03-26 2005-10-06 Hsc Research And Development Limited Partnership Novel compounds for modulating cell proliferation
EP2220054A2 (de) 2007-10-29 2010-08-25 Natco Pharma Limited Neue 4-(tetrazol-5-yl)chinazolinderivate als antikrebsmittel
CN106604725B (zh) 2014-07-03 2021-06-29 Nan全球有限责任公司 治疗肥胖症,防止体重增加,促进体重减轻或治疗或预防糖尿病的发展的方法和组合物
KR102925738B1 (ko) * 2018-10-04 2026-02-10 하이드로-퀘벡 Li-이온 배터리에서의 전해질용의 첨가제
PE20240801A1 (es) 2021-08-25 2024-04-18 Garcia Sada Fernando Composiciones y metodos para prevenir o reducir el riesgo del sindrome metabolico

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3522188A (en) * 1962-06-27 1970-07-28 Gaf Corp Use of alpha-alkyl (or alkenyl) benzylidene malononitriles as u.v. absorbers,and stabilized compositions and light filters containing same
US4064266A (en) * 1975-09-29 1977-12-20 Ici Australia Limited Compositions for killing internal parasites containing 3-tert-alkyl-4-hydroxy-5-halo-benzylidene-malonitriles
AU500541B2 (en) * 1975-09-29 1979-05-24 Ici Australia Limited Substituted benzylidene malonitriles
JPS6239523A (ja) * 1985-08-14 1987-02-20 Kanegafuchi Chem Ind Co Ltd 酵素阻害剤
US4781750A (en) * 1985-08-27 1988-11-01 Rohm And Haas Company Herbicidally active enols
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
DE68917357T2 (de) * 1988-04-28 1995-01-26 Suntory Ltd Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.

Also Published As

Publication number Publication date
CA1334826C (en) 1995-03-21
AU2736088A (en) 1989-06-29
EP0322738A2 (de) 1989-07-05
NZ227436A (en) 1992-10-28
EP0614661A2 (de) 1994-09-14
EP0614661A3 (de) 1994-11-02
EP0322738B1 (de) 1995-04-12
DE3853577D1 (de) 1995-05-18
JP2806954B2 (ja) 1998-09-30
EP0322738A3 (de) 1991-05-08
JPH10279477A (ja) 1998-10-20
DE3853577T2 (de) 1995-08-31
JPH02138238A (ja) 1990-05-28
AU632992B2 (en) 1993-01-21
ES2073398T3 (es) 1995-08-16

Similar Documents

Publication Publication Date Title
DE3853577D1 (de) Benzyliden-Malononitril-Derivate zur Hemmung von proliferativen Prozessen in Säugetierzellen.
ES2197160T3 (es) Antagonistas fibronogeno bicicliclos.
SE8201854L (sv) N-substituerade amino-aminosyror
DE3789967D1 (de) Anwendung von monoaminakridinen bei mangelerscheinungen des cholinergen nervensystems.
MX9306831A (es) Nuevos compuestos heterociclicos.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
FI942693A0 (fi) Pyridatsiinit interleukiini-1betaa muuttavan entsyymin inhibiittoreina
ES8401941A1 (es) Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico.
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
KR910006241A (ko) 피리미딘-4,6-디카복실산 디아미드, 이의 제조방법, 이의 용도 및 이들 화합물을 기초로 하는 약제
EP0353955A3 (de) Chemische Verbindungen
ATE224872T1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
MX9206930A (es) Nuevos compuestos
KR960022476A (ko) 디페닐 디설파이드 화합물
DK0514942T3 (da) Hidtil ukendte benzopyranderivater og fremgangsmåder til fremstilling deraf
HK67287A (en) Ergoline derivatives
NO872874D0 (no) Amid-derivater.
EA200200379A2 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
IL116382A0 (en) Trisubstituted t hoxanthines and pharmaceutical compositions containing the same
DK602383D0 (da) 1,1-diphenylpropanolderivater
MY104048A (en) New allylaminoethylazoles.
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
DE2963724D1 (en) Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee